Also trades as: GRNAW (NASDAQ) · $vol 0M
GRNA NASDAQ
GreenLight Biosciences Holdings
1W: +0.8%
1M: +2.9%
3M: -8.1%
1Y: -86.8%
$0.30
Last traded 2023-07-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$6M
+0.0% ▲
3Y CAGR: +28.6%
Gross Profit
$6M
+0.0% ▲
3Y CAGR: +28.6%
Operating Income
-$164M
-51.0% ▼
Net Income
-$167M
-45.6% ▼
EPS (Diluted)
$-1.27
-36.6% ▼
EBITDA
-$154M
-49.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | $3M | $962K | $0 | $6M |
| YoY Growth | +0.0% | -67.9% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $3M | $962K | $0 | $6M |
| Gross Margin | 100.0% | 100.0% | — | 100.0% |
| R&D Expenses | $23M | $43M | $90M | $134M |
| SG&A Expenses | $9M | $11M | $20M | $36M |
| Operating Expenses | $32M | $53M | $109M | $169M |
| Operating Income | -$29M | -$52M | -$109M | -$164M |
| Operating Margin | -973.1% | -5434.9% | — | -2567.7% |
| Interest Expense | $317K | $1M | $2M | $4M |
| Income Before Tax | -$29M | -$53M | -$112M | -$166M |
| Tax Expense | $317K | $1M | $2M | $1M |
| Net Income | -$29M | -$54M | -$115M | -$167M |
| Net Margin | -965.2% | -5642.3% | — | -2616.8% |
| EPS (Diluted) | $-0.30 | $-0.56 | $-0.93 | $-1.27 |
| EBITDA | -$28M | -$50M | -$103M | -$154M |
| Shares Outstanding | 96M | 96M | 123M | 132M |